Create

Sign in to ReadmeX

or

How we handle your data: Privacy Policy

ReadmeX

Your AI reading companion

What would you like to catch up on?

Pick a briefing, or ask your own question.

Your community and people briefings stay personal to you.

Story

Anthropic expands AI drug development and acquires Mithril

AI summary

Anthropic detailed early-stage drug-development work with six partners and said it had acquired Mithril, a one-person company focused on muscular dystrophy. The company said AI could speed drug development beyond common uses such as proposing initial designs for new molecules. The announcement did not name the six partners or provide independent results from the work.

In-depth insight

Anthropic’s reported collaborations and acquisition add drug development and muscular-dystrophy research to its stated AI-for-science activities.

This source provides an excerpt. Continue reading on the original site.

#Anthropic#Mithril

Read the original
Group chat

No comments yet. Start the conversation.